Case Control Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Jan 14, 2022; 28(2): 230-241
Published online Jan 14, 2022. doi: 10.3748/wjg.v28.i2.230
Table 2 Body mass index and risk of microscopic colitis

Cases
Controls



n = 101
n = 238
Crude
Adjusted1
BMI
n
%
n
%
OR (95%CI)
aOR (95%CI)
Overall
< 255049.57330.7Ref.Ref.
25 < 302928.76025.20.71 (0.40-1.25)0.70 (0.37-1.31)
≥ 302221.810544.10.31 (0.17-0.55)0.35 (0.18-0.66)
Women
< 254753.44728.7Ref.Ref.
25 -302427.33420.70.71 (0.36-1.37)0.67 (0.32-1.40)
≥ 301719.38350.60.20 (0.10-0.40)0.21 (0.10-0.45)
Men
< 25323.12635.1Ref.Ref.
25 -30538.52635.11.67 (0.36-7.71)2.22 (0.41-12.05)
≥ 30538.52229.71.97 (0.42-9.19)2.92 (0.52-16.22)
Lost weight
< 253460.73244.4Ref.Ref.
25 -301323.21723.60.72 (0.30-1.71)0.89 (0.35-2.22)
≥ 30916.12331.90.37 (0.15-0.91)0.49 (0.19-1.28)
No weight loss
< 251031.32019.4Ref.Ref.
25 -301340.63029.10.87 (0.31-2.36)0.64 (0.20-2.04)
≥ 30928.15351.50.33 (0.12-0.96)0.33 (0.10-1.11)
IBS
< 25969.21525.4Ref.Ref.
25-30215.41525.40.22 (0.04-1.21)0.26 (0.04-1.50)
≥ 30215.42949.20.11 (0.02-0.60)0.13 (0.02-0.76)
No IBS
< 253947.64732.6Ref.Ref.
25 -302631.73725.70.85 (0.44-1.63)0.78 (0.39-1.58)
≥ 301720.76041.70.34 (0.17-0.68)0.38 (0.18-0.79)